Paul Muntner, PhD

Ryals 140J

Paul M. Muntner, PhD, is a professor of Epidemiology and the School of Public Health Associate Dean of Research at the University of Alabama at Birmingham. Additionally, he is the co-director of the Pharmacoepidemiology and Economics Research Unit. He received his PhD in Epidemiology from Johns Hopkins School of Public Health in 2001. Dr. Muntner leads the NIH-funded Jackson Heart Study Hypertension Working Group and co-chairs the Coronary Artery Risk Development in Young Adults (CARDIA) study Hypertension Working Group. He is the director for the American Heart Association-funded Strategically Focused Research Network Hypertension center at UAB and is a co-principal investigator for an institutional career development program in HIV-related heart, lung, blood and sleep research. Additionally, he leads an academic-industry partnership between UAB, Mount Sinai School of Medicine and Amgen Inc. His research has been published in JAMA, The Lancet, Annals of Internal Medicine, and Circulation and featured on CNN and the New York Times and Washington Post.

Dr. Muntner has extensive experience in research leadership positions. He has served as chair of the writing committee for the American Heart Association's Scientific Statement on Blood Pressure Measurement, Vice Chair of the Statistics Committee for the American Heart Association and as a member of the American College of Cardiology/American Heart Association Guideline for the Management of Hypertension. From 2015 through 2018, he served as Deputy Editor for the Journal of the American Society of Hypertension. Currently, Dr. Muntner serves on the editorial boards of the American Journal of Kidney Diseases, American Journal of Cardiology, Journal of Clinical Hypertension and Journal of Hypertension. Additionally, from 2011 through 2014, he led the PhD program for the Department of Epidemiology at UAB.

Dr. Muntner's most recent research has focused on hypertension, high cholesterol and cardiovascular disease. He was the lead author on a recent national study that looked at the impact of the new American College of Cardiology and American Heart Association hypertension guideline. The study found that, under the new guideline, approximately 103.3 million people in the United States will be categorized as having high blood pressure.

Curriculum Vitae: